Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0M3Q stock hub

LON/0M3Q has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0M3Qis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

25.5B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0M3Q

In the news

Latest news · LON/0M3Q

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.8

P25 12.9P50 16.9P75 23.5

Trailing P/E12.6

P25 15.9P50 22.9P75 35.8

ROE67.7

P25 -54.2P50 2.1P75 13.7

ROIC27.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0M3Q market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	14,500
Employees Change	700%
Employees Change Percent	5.07
Enterprise value	$30.9B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US98978V1035
Last refreshed	2026-05-10
Market cap	$25.5B
Price	$83.47
Price currency	USD
Rev Per Employee	497,784.41x
Sector	Healthcare
Sic	2834
Symbol	lon/0M3Q
Website	https://www.zoetis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.94%
EV Earnings	15.25x
EV/EBIT	11.57x
EV/EBITDA	10.04x
EV/FCF	18.21x
EV/Sales	4.41x
FCF yield	6.65%
Forward P/E	11.81x
P/B ratio	10.41x
P/E ratio	12.59x
P/S ratio	3.53x
PE Ratio10 Y	36.43x
PE Ratio3 Y	30.21x
PE Ratio5 Y	34.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	38.12%
EBITDA Margin	42.74%
FCF margin	23.47%
Gross margin	71.84%
Gross Profit	$5.2B
Gross Profit Growth	4.18%
Gross Profit Growth Q	2.59%
Gross Profit Growth3 Y	6.75%
Gross Profit Growth5 Y	7%
Net Income	$2B
Net Income Growth	7.35%
Net Income Growth Q	-0.17%
Net Income Growth Years	10%
Net Income Growth3 Y	8.86%
Net Income Growth5 Y	8.54%
Pretax Margin	35.1%
Profit Margin	28.03%
Profit Per Employee	$139,553
Profitable Years	14
ROA	15.52
Roa5y	13.76
ROCE	27.73
ROE	67.75
Roe5y	52.61
ROIC	27.8
Roic5y	28.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-45.09%
Cagr3y	-22.48%
Cagr5y	-12.55%
Div CAGR3	9.9%
Div CAGR5	17.87%
EPS Growth	10.92
EPS Growth Q	5.88
EPS Growth Quarters	7
EPS Growth Years	10
EPS Growth3 Y	11.39
EPS Growth5 Y	10.48
FCF Growth	2.62%
FCF Growth Q	-13.65%
FCF Growth3 Y	15.34%
FCF Growth5 Y	5.87%
OCF Growth	-2.89%
OCF Growth Q	-22.14%
OCF Growth10 Y	15.59%
OCF Growth3 Y	9.04%
OCF Growth5 Y	5.67%
Revenue Growth	2.88x
Revenue Growth Q	2.91x
Revenue Growth Quarters	41x
Revenue Growth Years	10x
Revenue Growth3 Y	5.6x
Revenue Growth5 Y	6.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.65
Assets	$11.5B
Cash	$1.5B
Current Assets	$4.7B
Current Liabilities	$1.5B
Debt	$7B
Debt EBITDA	$2.21
Debt Equity	$2.86
Debt FCF	$4.14
Equity	$2.4B
Interest Coverage	15.8
Liabilities	$9B
Long Term Assets	$6.7B
Long Term Liabilities	$7.5B
Net Cash	$-5.5B
Net Cash By Market Cap	$-21.73
Net Debt EBITDA	$1.8
Net Debt Equity	$2.26
Net Debt FCF	$3.27
Tangible Book Value	$-381.7M
Tangible Book Value Per Share	$-0.91
WACC	7.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.15
Inventory Turnover	1.09
Net Working Capital	$1.9B
Quick ratio	1.68
Working Capital	$3.3B
Working Capital Turnover	$2.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.25%
Dividend Growth	6.2%
Dividend Growth Years	8%
Dividend per share	$1.54
Dividend Years	9
Dividend Yield	1.84%
Ex Div Date	2026-04-20
Last Dividend	$0.39
Payout Frequency	Quarterly
Payout Ratio	33.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-45.07%
200-day SMA	131.4
3Y total return	-53.43%
50-day SMA	117.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-48.85%
All Time High	248
All Time High Change	-66.34%
All Time High Date	2021-12-30
All Time Low	71.51
All Time Low Change	16.72%
All Time Low Date	2018-02-09
ATR	6.06
Beta	0.86
Ch YTD	-34.03
High	89.15
High52	172.2
High52 Date	2025-06-03
High52ch	-51.54%
Low	82.06
Low52	81.12
Low52 Date	2026-05-08
Low52ch	1.51%
Ma50ch	-28.96%
Price vs 200-day SMA	-36.48%
RSI	13.49
RSI Monthly	26.43
RSI Weekly	21.75
Sharpe ratio	-1.77x
Sortino ratio	-1.87
Total Return	5.1%
Tr YTD	-33.46
Tr1m	-28.44%
Tr1w	-26.99%
Tr3m	-34.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$2.8B
Operating Income Growth	6.32
Operating Income Growth Q	0.98
Operating Income Growth3 Y	8.11
Operating Income Growth5 Y	7.64
Operating margin	38.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	418,397,996%
Net Borrowing	1,695,150,854
Shares Insiders	0.09%
Shares Institutions	104.45%
Shares Qo Q	-3.69%
Shares Yo Y	-3.25%
Short Ratio	2.91

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.6B
Average Volume	8,625.6x
Bv Per Share	5.82
CAPEX	$-418.8M
Ch1m	-28.75
Ch1w	-26.99
Ch1y	-45.91
Ch3m	-34.65
Ch3y	-55.08
Ch5y	-51.37
Ch6m	-30.04
Change	-5.82%
Change From Open	-4.55
Close	88.63
Days Gap	-1.33
Depreciation Amortization	323,479,674
Dollar Volume	1,874,318.9
Earnings Date	2026-08-05
EBIT	$2.8B
EBITDA	$3.1B
EPS	$4.62
F Score	7
FCF	$1.7B
FCF EV Yield	5.49x
Financing CF	-1,539,601,065
Fiscal Year End	December
Founded	2,012
Goodwill	2,037,701,892
Graham Number	34.58203
Graham Upside	-58.57
Income Tax	$509.7M
Investing CF	-478,616,760
Is Primary Listing	0
Last Earnings Date	2026-02-13
Last Report Date	2026-03-31
Lynch Fair Value	$56.58
Lynch Upside	-32.21
Ma150	125.2
Ma150ch	-33.32%
Ma20	114
Ma20ch	-26.78%
Net CF	112,081,140
Next Earnings Date	2026-08-05
Open	87.45
P FCF Ratio	15.04
P OCF Ratio	12.06
Payment Date	2026-06-02
Position In Range	19.89
Ppne	2,934,789,514
Price Date	2026-05-08
Price EBITDA	$8.26
Relative Volume	3.18x
Revenue	7,217,873,955x
SBC By Revenue	0.95x
Share Based Comp	68,914,755
Tax By Revenue	7.06x
Tax Rate	20.12%
Tr6m	-29.43%
Volume	22,455
Z Score	6.21

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0M3Q dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$1.54 annual per share

Payout ratio

+33.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+17.9%

8 consecutive years of growth

Total shareholder yield

+5.1%

Next ex-dividend date: 2026-04-20

Performance

LON/0M3Q stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0M3Q?

Insider, institutional, and short-interest positioning.

Institutional ownership

+104.4%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0M3Q momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

13.5

Below 30: short-term oversold

Price vs 200-day MA

-36.5%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

-1.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0M3Q

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0M3Q stock rating?

lon/0M3Q is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0M3Q analysis?

The full report lives at /stocks/lon/0M3Q/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0M3Q?

The latest report frames lon/0M3Q around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0M3Q page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.